par Capelan, Marta 
;Pugliano, Lina;Azambuja, Evandro ;Bozovic, Ivana ;Saini, Kamal ;Sotiriou, Christos ;Loi, Sherene ;Piccart-Gebhart, Martine
Référence Annals of oncology
Publication Publié, 2012-08
;Pugliano, Lina;Azambuja, Evandro ;Bozovic, Ivana ;Saini, Kamal ;Sotiriou, Christos ;Loi, Sherene ;Piccart-Gebhart, Martine Référence Annals of oncology
Publication Publié, 2012-08
Article révisé par les pairs
| Titre: |
|
| Auteur: | Capelan, Marta; Pugliano, Lina; Azambuja, Evandro; Bozovic, Ivana; Saini, Kamal; Sotiriou, Christos; Loi, Sherene; Piccart-Gebhart, Martine |
| Informations sur la publication: | Annals of oncology |
| Statut de publication: | Publié, 2012-08 |
| Sujet CREF: | Cancérologie |
| MeSH keywords: | Antibodies, Monoclonal, Humanized -- adverse effects -- pharmacology -- therapeutic use |
| Antineoplastic Agents -- adverse effects -- pharmacology -- therapeutic use | |
| Breast Neoplasms -- drug therapy -- metabolism | |
| Dimerization | |
| Disease-Free Survival | |
| Female | |
| Humans | |
| Receptor, ErbB-2 -- immunology -- metabolism | |
| Note générale: | JOURNAL ARTICLE |
| SCOPUS: re.j | |
| Langue: | Autre |
| Identificateurs: | urn:issn:0923-7534 |
| info:doi/10.1093/annonc/mds328 | |
| info:pii/mds328 | |
| info:scp/84873804270 | |
| info:pmid/22910839 |
